Literature DB >> 8813336

Cytokines and the immune response.

P H Van der Meide1, H Schellekens.   

Abstract

Cytokines participate in many physiological processes including the regulation of immune and inflammatory responses. These effector molecules are produced transiently and locally controlling the amplitude and duration of the response. A variety of experiments has shown that excessive or insufficient production may significantly contribute to the pathophysiology of a range of diseases. Particularly cytokines released by CD4+ T cells at the onset of an immune response are thought to be decisive for pathological or physiological consequences. The meeting in Budapest was focussed on cytokines known to contribute to the pathophysiology of autoimmune diseases, infectious diseases and allograft rejection (e.g., IL-1, IL-4, IL-6, IL-10, IL-12, TNF-alpha and IFN-alpha, -beta, -gamma). A central role for IFN-gamma in autoimmunity was suggested by blocking experiments in vivo using monoclonal antibodies and soluble forms of the IFN-gamma receptor (IFN-gamma SR). These agents ameliorated disease development in a variety of experimental autoimmune diseases in rodents. In a mouse model for the human disease Myasthenia gravis, IFN-alpha was found to reduce both the incidence and progression of the disease. Treatment of R. aurantiacus-infected mice with anti-IL-4 monoclonal antibodies (mAbs) was reported to interfere with the regression of granulomas in spleen and liver, most likely through inadequate IL-4-mediated suppression of IFN-gamma production. In addition, it was shown that mice with disrupted IFN-gamma R genes died rapidly after infection with the BCG strain of M. bovis, whereas normal mice survived the infection. IL-12 was found to be the main inductor of IFN-gamma during the lethal Shwartzman reaction. TNF-alpha was identified as the principal cause of mortality after the second injection with LPS. In a variety of studies examining the role of cytokines in the pathogenesis of AIDS, much attention was given to the in vitro effects of HIV-1 and/or the HIV-1 viral membrane protein gp120 on triggering cytokine production by peripheral blood leukocytes (PBLs) and purified monocytes/macrophages (Mø) originating from healthy donors. Gp120 as a sole agent significantly suppressed IFN-gamma production by mitogen-stimulated PBLs and induced the production of IFN-alpha in cultures of normal human peripheral blood mononuclear cells (PBMCs). In a human macrophage cell line, TNF-alpha exerted a stimulatory effect on viral replication and programmed cell death induced by HIV-1 which was potentiated by the simultaneous incubation with IFN-gamma. Upon transfection of human PBLs and CD4+ T cells with a retroviral vector encoding human IFN-beta, a notable reduction in reverse transcriptase activity after HIV-1 challenge was observed. Gp120 was also found to induce both IL-6 and TNF-alpha expression and to induce morphological changes reminiscent for apoptosis in primary astrocytes and in a re-aggregated human brain cell model, suggesting a role for these cytokines in the neuropathology of AIDS dementia. Moreover, data were presented indicating that cytokine-induced expression of cell adhesion molecules (e.g., ICAM-1) in HIV-1 infected U 937 cells leads to high level incorporation of this molecule in the membrane of the viral progeny which may play a role in the attachment of such virions to CD4-negative cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813336     DOI: 10.1007/bf01877210

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  44 in total

1.  Active Delivery of VLPs Promotes Anti-Tumor Activity in a Mouse Ovarian Tumor Model.

Authors:  Chao Wang; Berta Esteban Fernández de Ávila; Rodolfo Mundaca-Uribe; Miguel Angel Lopez-Ramirez; Doris E Ramírez-Herrera; Sourabh Shukla; Nicole F Steinmetz; Joseph Wang
Journal:  Small       Date:  2020-04-24       Impact factor: 13.281

2.  Assessment of immune activation in mice before and after eradication of mite infestation.

Authors:  Nancy A Johnston; Rita A Trammell; Susan Ball-Kell; Steven Verhulst; Linda A Toth
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

3.  Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha.

Authors:  Swapan K De; Krishnakumar Devadas; Abner Louis Notkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects.

Authors:  Tomonori Hayashi; Yukari Morishita; Ravindra Khattree; Munechika Misumi; Keiko Sasaki; Ikue Hayashi; Kengo Yoshida; Junko Kajimura; Seishi Kyoizumi; Kazue Imai; Yoichiro Kusunoki; Kei Nakachi
Journal:  FASEB J       Date:  2012-08-07       Impact factor: 5.191

Review 5.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Authors:  Sachin Kumar Deshmukh; Sanjeev Kumar Srivastava; Teja Poosarla; Donna Lynn Dyess; Nicolette Paolaungthong Holliday; Ajay Pratap Singh; Seema Singh
Journal:  Ann Transl Med       Date:  2019-10

6.  Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation.

Authors:  Marcie R Kritzik; Cory U Lago; Ayse G Kayali; Sandrine Arnaud-Dabernat; Guoxun Liu; You-Qing Zhang; Hong Hua; Howard S Fox; Nora E Sarvetnick
Journal:  Endocrine       Date:  2010-01-09       Impact factor: 3.633

Review 7.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

8.  SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2010-07-19       Impact factor: 2.563

9.  Opioid-like activity of naltrexone on natural killer cell cytolytic activity and cytokine production in splenocytes: effects of alcohol.

Authors:  Nadka I Boyadjieva; Dipak K Sarkar
Journal:  J Interferon Cytokine Res       Date:  2010-01       Impact factor: 2.607

10.  Development of CD4+ T cell lines that suppress an antigen-specific immune response in vivo.

Authors:  L Vieira de Moraes; B Sun; L V Rizzo
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.